| pubmed-article:9506570 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9506570 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:9506570 | lifeskim:mentions | umls-concept:C1457887 | lld:lifeskim |
| pubmed-article:9506570 | lifeskim:mentions | umls-concept:C0024141 | lld:lifeskim |
| pubmed-article:9506570 | lifeskim:mentions | umls-concept:C0014792 | lld:lifeskim |
| pubmed-article:9506570 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:9506570 | lifeskim:mentions | umls-concept:C0003313 | lld:lifeskim |
| pubmed-article:9506570 | lifeskim:mentions | umls-concept:C0700364 | lld:lifeskim |
| pubmed-article:9506570 | lifeskim:mentions | umls-concept:C1609982 | lld:lifeskim |
| pubmed-article:9506570 | lifeskim:mentions | umls-concept:C0679823 | lld:lifeskim |
| pubmed-article:9506570 | lifeskim:mentions | umls-concept:C0033453 | lld:lifeskim |
| pubmed-article:9506570 | lifeskim:mentions | umls-concept:C1441672 | lld:lifeskim |
| pubmed-article:9506570 | lifeskim:mentions | umls-concept:C2266866 | lld:lifeskim |
| pubmed-article:9506570 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:9506570 | lifeskim:mentions | umls-concept:C0205421 | lld:lifeskim |
| pubmed-article:9506570 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:9506570 | pubmed:dateCreated | 1998-4-14 | lld:pubmed |
| pubmed-article:9506570 | pubmed:abstractText | To investigate whether participation of factor B (FB) in immune complex transport might explain long periods of clinical remissions in a homozygous C2-deficient patient with systemic lupus erythematosus (SLE) treated regularly with plasma infusions. | lld:pubmed |
| pubmed-article:9506570 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9506570 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9506570 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9506570 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9506570 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9506570 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9506570 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9506570 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9506570 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9506570 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9506570 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:9506570 | pubmed:issn | 0004-3591 | lld:pubmed |
| pubmed-article:9506570 | pubmed:author | pubmed-author:ValdimarssonH... | lld:pubmed |
| pubmed-article:9506570 | pubmed:author | pubmed-author:ErlendssonKK | lld:pubmed |
| pubmed-article:9506570 | pubmed:author | pubmed-author:SteinssonKK | lld:pubmed |
| pubmed-article:9506570 | pubmed:author | pubmed-author:Traustadóttir... | lld:pubmed |
| pubmed-article:9506570 | pubmed:author | pubmed-author:RafnarB OBO | lld:pubmed |
| pubmed-article:9506570 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9506570 | pubmed:volume | 41 | lld:pubmed |
| pubmed-article:9506570 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9506570 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9506570 | pubmed:pagination | 427-34 | lld:pubmed |
| pubmed-article:9506570 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9506570 | pubmed:meshHeading | pubmed-meshheading:9506570-... | lld:pubmed |
| pubmed-article:9506570 | pubmed:meshHeading | pubmed-meshheading:9506570-... | lld:pubmed |
| pubmed-article:9506570 | pubmed:meshHeading | pubmed-meshheading:9506570-... | lld:pubmed |
| pubmed-article:9506570 | pubmed:meshHeading | pubmed-meshheading:9506570-... | lld:pubmed |
| pubmed-article:9506570 | pubmed:meshHeading | pubmed-meshheading:9506570-... | lld:pubmed |
| pubmed-article:9506570 | pubmed:meshHeading | pubmed-meshheading:9506570-... | lld:pubmed |
| pubmed-article:9506570 | pubmed:meshHeading | pubmed-meshheading:9506570-... | lld:pubmed |
| pubmed-article:9506570 | pubmed:meshHeading | pubmed-meshheading:9506570-... | lld:pubmed |
| pubmed-article:9506570 | pubmed:meshHeading | pubmed-meshheading:9506570-... | lld:pubmed |
| pubmed-article:9506570 | pubmed:meshHeading | pubmed-meshheading:9506570-... | lld:pubmed |
| pubmed-article:9506570 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9506570 | pubmed:articleTitle | Participation of factor B in residual immune complex red cell binding activity observed in serum from a C2-deficient systemic lupus erythematosus patient may delay the appearance of clinical symptoms. | lld:pubmed |
| pubmed-article:9506570 | pubmed:affiliation | The National University Hospital, Landspítalinn, Reykjavik, Iceland. | lld:pubmed |
| pubmed-article:9506570 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9506570 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9506570 | lld:pubmed |
